patents.google.com

AU2003254865A1 - Akt2-BINDING PROTEIN - Google Patents

  • ️Wed Feb 25 2004

AU2003254865A1 - Akt2-BINDING PROTEIN - Google Patents

Akt2-BINDING PROTEIN

Info

Publication number
AU2003254865A1
AU2003254865A1 AU2003254865A AU2003254865A AU2003254865A1 AU 2003254865 A1 AU2003254865 A1 AU 2003254865A1 AU 2003254865 A AU2003254865 A AU 2003254865A AU 2003254865 A AU2003254865 A AU 2003254865A AU 2003254865 A1 AU2003254865 A1 AU 2003254865A1 Authority
AU
Australia
Prior art keywords
akt2
binding protein
protein
binding
Prior art date
2002-08-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003254865A
Inventor
Yuki Endo
Hideki Endoh
Miyuki Kato
Yohei Masunaga
Hiroaki Tanaka
Yoshitaka Ueda
Noboru Yamaji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2002-08-09
Filing date
2003-08-07
Publication date
2004-02-25
2003-08-07 Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
2004-02-25 Publication of AU2003254865A1 publication Critical patent/AU2003254865A1/en
Status Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003254865A 2002-08-09 2003-08-07 Akt2-BINDING PROTEIN Abandoned AU2003254865A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002233217 2002-08-09
JP2002-233217 2002-08-09
PCT/JP2003/010075 WO2004015103A1 (en) 2002-08-09 2003-08-07 Akt2-BINDING PROTEIN

Publications (1)

Publication Number Publication Date
AU2003254865A1 true AU2003254865A1 (en) 2004-02-25

Family

ID=31711857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003254865A Abandoned AU2003254865A1 (en) 2002-08-09 2003-08-07 Akt2-BINDING PROTEIN

Country Status (3)

Country Link
JP (1) JPWO2004015103A1 (en)
AU (1) AU2003254865A1 (en)
WO (1) WO2004015103A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006296251A (en) * 2005-04-19 2006-11-02 Gunze Ltd alpha-GLUCOSIDASE INHIBITOR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000157269A (en) * 1998-11-24 2000-06-13 Japan Science & Technology Corp Reverse two-hybrid method using galactose sensibility
JP2002058489A (en) * 2000-08-22 2002-02-26 Osaka Bioscience Institute Method of screening for insulin sensitizer in diabetes

Also Published As

Publication number Publication date
JPWO2004015103A1 (en) 2005-12-02
WO2004015103A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2003290563A1 (en) 2004-05-25 Leptin-related peptides
AU2003272454A1 (en) 2004-04-08 Protein purification
AU2002354472A1 (en) 2004-03-29 Combine
AU2003226899A1 (en) 2003-09-29 Human diabetes-mediating proteins
EP1576115A3 (en) 2005-11-09 Protein chips
AU2003295462A1 (en) 2004-06-03 Lipid-associated proteins
AU2003205623A1 (en) 2003-07-30 Prion protein carrier-conjugates
AU2002355026A1 (en) 2004-04-30 Combine
AU2003202694A1 (en) 2003-09-02 Torero protein
AU2003254001A1 (en) 2004-03-03 Novel htnfsf13b protein variants
AU2003278718A1 (en) 2004-03-11 Stars-a muscle-specification-binding protein
AU2003236374A1 (en) 2003-10-20 Atopic dermatitis-inducing proteins
AU2003270055A1 (en) 2004-03-29 Neurotransmission-associated proteins
AU2003300785A1 (en) 2004-06-03 Carbohydrate-associated proteins
AU2003254865A1 (en) 2004-02-25 Akt2-BINDING PROTEIN
AU2003236908A1 (en) 2004-01-06 Proteins
AU2003295760A1 (en) 2004-06-18 Organelle-associated proteins
AU2003218714A1 (en) 2003-09-22 Rhomboid-related protein
AU2003281671A1 (en) 2004-02-16 Brca1-interacting protein
AU2003229752A1 (en) 2003-11-17 Human rhomboid-related protein
GB0204735D0 (en) 2002-04-17 Protein
GB0202748D0 (en) 2002-03-27 Protein
AU2003905886A0 (en) 2003-11-06 Protein expression
AU2003303642A1 (en) 2004-07-29 Synthetic neutropoiesis-stimulating proteins
AU2003211501A1 (en) 2003-09-02 Peptides

Legal Events

Date Code Title Description
2005-05-05 MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase